Product NDC: | 0078-0102 |
Proprietary Name: | Parlodel |
Non Proprietary Name: | bromocriptine mesylate |
Active Ingredient(s): | 5 mg/1 & nbsp; bromocriptine mesylate |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0078-0102 |
Labeler Name: | Novartis Pharmaceuticals Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA017962 |
Marketing Category: | NDA |
Start Marketing Date: | 19780628 |
Package NDC: | 0078-0102-15 |
Package Description: | 30 CAPSULE in 1 PACKAGE (0078-0102-15) |
NDC Code | 0078-0102-15 |
Proprietary Name | Parlodel |
Package Description | 30 CAPSULE in 1 PACKAGE (0078-0102-15) |
Product NDC | 0078-0102 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | bromocriptine mesylate |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19780628 |
Marketing Category Name | NDA |
Labeler Name | Novartis Pharmaceuticals Corporation |
Substance Name | BROMOCRIPTINE MESYLATE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] |